| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $4.53M | $3.79M | $3.49M | $3.45M | $5.92M |
| R&D | – | – | – | – | – |
| SG&A | $30.03K | $27.68K | $31.90K | $28.53K | $33.29K |
| Operating Income | – | – | – | – | – |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | $0.00 | $0.00 | $0.00 |
| Net Income | -$4.64M | -$3.60M | -$3.40M | -$3.04M | -$5.98M |
| EPS (basic) | -0.0200 | -0.0200 | -0.0200 | -0.0200 | -0.0300 |
| EPS (diluted) | -0.0200 | -0.0200 | -0.0200 | -0.0200 | -0.0300 |
| Shares (diluted) | $207.89M | $199.65M | $195.62M | $195.22M | $194.91M |